Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Helmut R. Maecke"'
Autor:
Keelara Abiraj, Samer Ursillo, Maria Luisa Tamma, Svetlana N. Rylova, Beatrice Waser, Edwin C. Constable, Melpomeni Fani, Guillaume P. Nicolas, Jean Claude Reubi, Helmut R. Maecke
Publikováno v:
EJNMMI Research, Vol 8, Iss 1, Pp 1-10 (2018)
Abstract Background Somatostatin receptor targeting radiopeptides are successfully being used to image, stage, and monitor patients with neuroendocrine tumours. They are exclusively agonists that internalise upon binding to the relevant receptor. Acc
Externí odkaz:
https://doaj.org/article/3e6f8fdce56940b8921dfb43b004e7dc
Autor:
Helmut R. Maecke, Jean Claude Reubi, Renzo Cescato, Beatrice Waser, Maria-Luisa Tamma, Stefan Kneifel, Flavio Forrer, Xuejuan Wang, Rosalba Mansi
Supplementary Data from Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid–Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9087d798b8f816e6ecb1b526cf39e429
https://doi.org/10.1158/1078-0432.22440334
https://doi.org/10.1158/1078-0432.22440334
Autor:
Helmut R. Maecke, Jean-Claude Reubi, Anne Provencher-Bolliger, Julie Boisclair, Frank Bruchertseifer, Alfred Morgenstern, Hanwen Zhang, Michael Frischknecht, Damian Wild
Supplementary Table 1 from Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34939e7f3f9378a6028445e14bd1048b
https://doi.org/10.1158/0008-5472.22387452.v1
https://doi.org/10.1158/0008-5472.22387452.v1
Autor:
Helmut R. Maecke, Jean-Claude Reubi, Anne Provencher-Bolliger, Julie Boisclair, Frank Bruchertseifer, Alfred Morgenstern, Hanwen Zhang, Michael Frischknecht, Damian Wild
Supplementary Table 3 from Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32895aeb32a667c785ce4c6c92c4bc18
https://doi.org/10.1158/0008-5472.22387446
https://doi.org/10.1158/0008-5472.22387446
Autor:
Helmut R. Maecke, Jean-Claude Reubi, Anne Provencher-Bolliger, Julie Boisclair, Frank Bruchertseifer, Alfred Morgenstern, Hanwen Zhang, Michael Frischknecht, Damian Wild
Supplementary Figures 1-4 from Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52085c316efb4106efb5861c48a46f85
https://doi.org/10.1158/0008-5472.22387455.v1
https://doi.org/10.1158/0008-5472.22387455.v1
Autor:
Helmut R. Maecke, Jean-Claude Reubi, Anne Provencher-Bolliger, Julie Boisclair, Frank Bruchertseifer, Alfred Morgenstern, Hanwen Zhang, Michael Frischknecht, Damian Wild
Supplementary Table 2 from Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10cbc61e69ed4c239d2da6455e9e72e2
https://doi.org/10.1158/0008-5472.22387449.v1
https://doi.org/10.1158/0008-5472.22387449.v1
Autor:
Svetlana N Rylova, Christian Stoykow, Luigi Del Pozzo, Keelara Abiraj, Maria Luisa Tamma, Yvonne Kiefer, Melpomeni Fani, Helmut R Maecke
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195802 (2018)
Copper-64 is an attractive radionuclide for PET imaging and is frequently used in clinical applications. The aim of this study was to perform a side-by-side comparison of the in vitro and in vivo performance of 64Cu-NODAGA-JR11 (NODAGA = 1,4,7-triaza
Externí odkaz:
https://doaj.org/article/75175acc042448a59009fd3d214ea109
Autor:
Eleni Gourni PhD, Luigi Del Pozzo BSc, Mark Bartholomä PhD, Yvonne Kiefer BSc, Philipp T. Meyer MD, PhD, Helmut R. Maecke PhD, Jason P. Holland D.Phil
Publikováno v:
Molecular Imaging, Vol 16 (2017)
Radiotracers incorporating the urea-based Glu-NH-C(O)-NH-Lys group have gained prominence due to their role in targeting prostate-specific membrane antigen (PSMA)—a clinical biomarker of prostate cancer. Here, the synthesis, radiolabeling, and in v
Externí odkaz:
https://doaj.org/article/80fc5fd6557c4066a3ee4da24b33cef8
Autor:
Tilman Läppchen, Roswitha Tönnesmann, Jos Eersels, Philipp T Meyer, Helmut R Maecke, Svetlana N Rylova
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170435 (2017)
GLP-1 receptors are ideal targets for preoperative imaging of benign insulinoma and for quantifying the beta cell mass. The existing clinical tracers targeting GLP-1R are all agonists with low specific activity and very high kidney uptake. In order t
Externí odkaz:
https://doaj.org/article/ef62f5584b584fdda76a5318d677e015
Autor:
Kerstin Michalski, C. Stoykow, Juri Ruf, Katharina Laubner, Helmut R. Maecke, Philipp T. Meyer, Christian Goetz, Mohamed Aymen Omrane, Jochen Seufert
Publikováno v:
Clinical Nuclear Medicine. 45:519-524
Purpose Insulinomas are predominantly benign neuroendocrine tumors originating from beta cells within the islets of Langerhans of the endocrine pancreas. Because surgical resection represents the only curative therapy option, exact tumor localization